Brand Name: VACUETTE Product Name: LH Lithium Heparin Separator… — Class II medical device recall Z-0200-2027
Ongoing recall by Greiner Bio-One North America, Inc., reported 2026-10-28, distributed nationwide. Lot B26043FM may include EDTA contamination which introduces potassium while chelating calcium in patient samp
| Recall number | Z-0200-2027 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Greiner Bio-One North America, Inc., Monroe, NC, United States |
| Recall initiated | 2026-07-29 |
| Classified | 2026-10-21 |
| Reported by FDA | 2026-10-28 |
| Distributed | Nationwide (US) |
| Quantity | 860,450 |
| UPC / GTIN / UDI-DI | 29120017579032, 39120017579039 |
| Lot numbers | B26043FM |
| Model numbers | 454008P |
| Expiration dates | 2027-07-12 |
Product
Brand Name: VACUETTE Product Name: LH Lithium Heparin Separator Model/Catalog Number: 454008P Product Description: Greiner VACUETTE Blood Collection Tube with Lithium Heparin and Gel Separator (13 x 75 mm, 3.5ml)
Reason for recall
Lot B26043FM may include EDTA contamination which introduces potassium while chelating calcium in patient samples, leading to falsely elevated potassium (K+) and falsely decreased calcium (Ca++) results which have the potential to cause hyperkalemia.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0200-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-03. Not affiliated with or endorsed by FDA. Not medical or legal advice.